Cognitive dysfunction and subjective complaints of cancer patients: A cross-sectional study in a cancer rehabilitation centre

European Journal of Cancer

Volumn 40, Issue 1, 2004, Pages 43-49

  Poppelreuter, M ^a   Weis, J ^a   Kulz A K ^b   Tucha, O ^c   Lange, K W ^c   Bartsch, H H ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cancer; Neuropsychological diagnostics; Neurotoxicity; Oncological rehabilitation; Psycho oncology; Quality of life

Indexed keywords

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CANCER; CANCER CENTER; CANCER PATIENT; CLINICAL FEATURE; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEPRESSION; HUMAN; MEDICAL INFORMATION; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; QUESTIONNAIRE; RANDOMIZATION; SELF REPORT;

EID: 0345735492     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.08.001     Document Type: Article

References (29)

1. Chao N.J., Tierney D.K., Bloom J.R.et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood. 80:1992;825-830.
2. Bullinger M. Gesundheitsbezogene Lebensqualität und subjektive Gesundheit. Psychother. Psychosom. Med. Psychol. 47:1997;76-91.
3. Walch S.E., Ahles T.A., Saykin A.J. Neuropsychological impact of cancer and cancer treatments. Holland J. Psychooncology. 1999;500-505 Oxford University Press, New York.
4. Weiss H.D., Walker M.D., Wiernik P.H. Neurotoxicity of commonly used antineoplastic agents. N. Engl. J. Med. 11:1974;75-81.
5. Folstein M.F., Fetting J.H., Lobo A., Niaz U., Capozzoli K.D. Cognitive assessment of cancer patients. Cancer. 53:1984;2250-2257.
6. Andrykowski M.A., Schmitt F.A., Gregg M.E., Brady M.J., Lamb D.G., Henslee-Downey P.J. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer. 70:1992;2288-2297.
7. Meyers C., Abbruzzese J.L. Cognitive functioning in cancer patients. effect of previous treatment Neurology. 42:1992;434-436.
8. Meyers C.A., Weitzner M., Byrne K., Valentine A., Champlin R.E., Przepiorka D. Evaluation of the neurobehavioural functioning of patients before, during and after bone marrow transplantation. J. Clin. Oncol. 12:1994;820-826.
9. Ahles T.A., Tope D.M., Furstenberg C., Hann D., Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J. Clin. Oncol. 14:1996;1457-1462.
10. Padovan C.S., Tarek A.Y., Schleuning M., Holler E., Kolb H.J., Straube A. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann. Neurol. 43:1998;627-633.
11. Andrykowski M.A., Henslee P.J., Barnett R.L. Longitudinal assessment of psychosocial functioning of adult survivors of allogenic bone marrow transplantation. Bone Marrow Transplant. 4:1989;505-509.
12. Cull A., Hay C., Love S.B., Mackie M., Smets E., Stewart M. What do cancer patients mean when they complain of concentration and memory problems? Br. J. Cancer. 74:1996;1674-1679.
13. Ahles T.A., Saykin A.J., Furstenberg C.T.et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J. Clin. Oncol. 20:2002;485-493.
14. Wieneke M.H., Dienst E.R. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology. 4:1995;61-66.
15. Schagen S.B., Van Dam F.S.A.M., Muller M.J., Boogerd W., Lindeboom J., Bruning P.F. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 85:1999;640-650.
16. Brezden C.B., Phillips K.A., Abdolell M., Bunston T., Tannock I.F. Cognitive functioning in breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 18:2000;2695-2701.
17. Van Dam F.S.A.M., Schagen S.B., Muller M.J.et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer. high-dose versus standard-dose chemotherapy J. Natl. Cancer Inst. 90:1998;210-218.
18. Weis J., Bartsch H.H., Nagel G.A., Unger C. Psychosocial care for cancer patients. a new holistic psychosomatic approach in acute care and rehabilitation Psycho-Oncology. 5:1996;51-54.
19. Lezak M.D. Neuropsychological Assessment. 3rd edn. 1995;Oxford University Press, New York.
20. Wechsler D. Wechsler Memory Scale-Revised Form (WMS-R). 1987;The Psychological Corporation, San Antonio.
21. Reitan R.M. Validity of the trail making test as an indication of organic brain damage. Percept Mot. Skills. 8:1958;271-276.
22. Zimmermann P., Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Version 1.02c:1994;Psytest, Würselen.
23. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). 1992;Straube, Erlangen.
24. Zimmermann P., Messner C., Poser U., Sedelmeier P. Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA). 1991;Institute of Psychology of the University, Freiburg.
25. Herrmann C.H., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale - German Version (HADS-D). 1995;Huber, Bern.
26. Carroll B.T., Kathol R.G., Noyes R., Wald T.G., Clamon G.H. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen. Hosp. Psych. 15:1993;69-74.
27. Brouwers P., Poplack D. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia. association with attention deficits Am. J. Ped. Hematol. Oncol. 12:1990;174-181.
28. Rodgers J., Horrocks J., Britton P.G., Kernahan J. Attentional ability among survivors of leukemia. Arch. Dis. Childhood. 80:1999;318-323.
29. Schuri U., Keller I., Matthes-von Cramon G. Leistungsdiagnostik aus neuropsychologischer Sicht. Stieglitz R.D., Baumann U. Psychodiagnostik psychischer Störungen. 1994;138-148 Enke, Stuttgart.